Lifecore Biomedical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Lifecore Biomedical generated cash of -$217,000, which is more than the previous year. Cash used in financing activities reached the amount of $7,509,000 last year. Net change in cash is therefore -$10,629,000.
Cash Flow
| 2015 | 26.15M | -34.44M | 8.16M |
|---|---|---|---|
| 2016 | 21.78M | -41.59M | 15.57M |
| 2017 | 29.32M | -25.01M | -8.80M |
| 2018 | 19.77M | -35.58M | 13.29M |
| 2019 | 16.02M | -96.79M | 79.02M |
| 2020 | -17.04M | -23.88M | 40.01M |
| 2021 | 15.01M | -10.85M | -3.41M |
| 2022 | -24.39M | 81.76M | -57.02M |
| 2023 | -34.45M | -4.15M | 39.7M |
| 2024 | -217K | -17.92M | 7.50M |
LFCR Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 19.09M | 1.64M | 1.29M | 553K | 1.46M | 3.21M | 5.40M | 9.89M | 14.12M | 14.24M |
Operating activities | ||||||||||
Net income | 9.33M | -102.19M | -97.23M | -32.66M | -38.19M | 411K | 24.92M | 10.67M | -11.44M | 13.72M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 8.85M | 13.50M | 17.78M | 19.86M | 18.83M | 15.23M | 12.41M | 10.67M | 9.39M | 7.09M |
Stock-based compensation expense | 6.20M | 3.61K | 2.64K | 3.36M | 2.41M | 3.56M | 0 | 3.96M | 3.46M | 1.57M |
| Deferred income tax benefit | 6.20M | 3.61K | 2.64K | 3.36M | 2.41M | 3.56M | 0 | 3.96M | 3.46M | 1.57M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -2.39M | 12.19M | -6.29M | 5.77M | -6.64M | -8.86M | -7.31M | -336K | 73K | -1.75M |
Inventories | 862K | -13.82M | -6.08M | -3.35M | -12.17M | -10.92M | -6.52M | 855K | -508K | -292K |
Accounts payable | -6.67M | 16.08M | 9.34M | -5.98M | -1.24M | 19.11M | 4.96M | -5.18M | -4.10M | 2.89M |
Cash generated by operating activities | -217K | -34.45M | -24.39M | 15.01M | -17.04M | 16.02M | 19.77M | 29.32M | 21.78M | 26.15M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 264K | 0 | 0 | 0 | -18M |
Investments In Property Plant And Equipment | -17.92M | -20.76M | -28.13M | -23.76M | -26.68M | -44.73M | -33.59M | -22.59M | -40.86M | -17.51M |
Acquisitions Net | 0 | 16.61M | 63.66M | 12.91M | 2.43M | -59.87M | -4.11M | -2.5M | -121K | 0 |
Cash generated by investing activities | -17.92M | -4.15M | 81.76M | -10.85M | -23.88M | -96.79M | -35.58M | -25.01M | -41.59M | -34.44M |
Financing activities | ||||||||||
Common Stock Issued | 724K | 4.82M | 0 | 0 | 30K | 327K | 56K | 706K | 322K | 122K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -152K | 0 | -789K | -405K | -212K | 0 | -1.47M | 0 | 0 | 0 |
Repayments of term debt | 2.74M | 3.12M | -55.41M | -262.53M | -105.02M | 54.90M | -14.07M | -8.63M | -37.25M | 8.14M |
Cash used in financing activities | 7.50M | 39.7M | -57.02M | -3.41M | 40.01M | 79.02M | 13.29M | -8.80M | 15.57M | 8.16M |
Net Change In Cash | -10.62M | 17.44M | 348K | 742K | -912K | -1.75M | -2.51M | -4.48M | -4.23M | -116K |
Cash at end of period | 8.46M | 19.09M | 1.64M | 1.29M | 553K | 1.46M | 2.89M | 5.40M | 9.89M | 14.12M |
| Data source | Data source | Data source |